Privacy Policy - Amprion DX

A pioneer in the science of detecting mis-folded proteins, Amprion advances the diagnosis of brain disorders. Our SYNTap™️ Biomarker Test aids physicians in diagnosing Parkinson’s, Lewy Body Dementia, and Alzheimer’s with Lewy Body variant. We plan to launch more biomarker tests in the future.

Company

Support

Clinical Lab

This website is intended for the informational purposes of healthcare professionals.
AMPRION & SYNTap are registered trademarks of Amprion Inc. © 2007-2023 Amprion Inc. All rights reserved.

Please Note: Important Billing Info

To improve patient access to the SYNTap® Biomarker CSF Test, Amprion offers the following billing options:

List price of $1500, with courtesy billing for both Medicare and private insurance.
An affordable self-pay price of $995 (patients may qualify for financial assistance and/or interest-free payment options).
Prices are effective as of January 1, 2024, and are subject to change.

Please note: Amprion is a Medicare participating provider, however, the SYNTap test does not currently have Medicare coverage determination. Also, Amprion is not yet in network with most insurers.

The SYNTap Biomarker CSF Test has been issued a dedicated CPT® PLA code to be used when billing: 0393U.

For additional information, please visit our billing page.